Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Constellium to Exhibit at the 2025 Paris Air Show
-
Start of Day Message
-
Roche to advance prasinezumab into Phase III development for early-stage Parkinson's disease
-
WISeKey Appoints Rolf Gobet to its Strategic Advisory Committee
-
PAIRMiner Reports Surge in User Growth and Platform Activity Amid Bitcoin Market Rally
-
Jack L. Marcus, Inc. Issues Notice of Privacy Breach Affecting Wisconsin Department of Corrections Population
-
EHA 2025 | Multiple Studies Report Encouraging Data of Olverembatinib in Ph+ ALL
-
Abaxx Confirms Active Trading in Gold Singapore Futures Following Launch
-
Bombardier's Record-Setting Global 7500 Aircraft Earns New Speed Record Between Montréal and Paris
-
Bombardier's Record-Setting Global 7500 Aircraft Earns New Speed Record Between Montréal and Paris
-
Share issue to personnel – 14 June 2025
-
June Surge: AIXA Miner Hits Major Milestone as Green Cloud Mining Goes Global
-
Ahead of the $3 XRP Era, PFMCrypto Launches 2-Day XRP Mining Promotion, $1 Million Giveaway Sparks Community Excitement
-
Inside information, negative profit warning - Oma Savings Bank Plc lowers its earnings guidance for 2025
-
Announcement regarding the governance of Renault Group
-
CGTN: From father to son: The enduring values guiding Xi Jinping
-
Press Release: EAACI: Dupixent demonstrated superiority over Xolair (omalizumab) in chronic rhinosinusitis with nasal polyps in patients with coexisting asthma in first-ever presented phase 4 head-to-
-
Dupixent® (dupilumab) Demonstrated Superiority Over Xolair® (Omalizumab) in Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) in Patients with Coexisting Asthma in First-ever Presented Phase 4 Head-
-
Intellia Therapeutics Announces Positive Three-Year Data from Phase 1 Trial of Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema (HAE) at the European Academy of Allergy and Clini
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Summit Therapeutics Inc. - SMMT
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NWTN Inc. - NWTN
-
Pomerantz Law Firm Announces the Filing of a Class Action Against PepGen Inc. and Certain Officers – PEPG
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zeo Energy Corp. - ZEO
-
Pomerantz Law Firm Announces the Filing of a Class Action Against Red Cat Holdings, Inc. and Certain Officers – RCAT
-
Pomerantz Law Firm Announces the Filing of a Class Action Against Fortrea Holdings, Inc. and Certain Officers – FTRE
-
Pomerantz Law Firm Announces the Filing of a Class Action Against MicroStrategy Incorporated d/b/a Strategy and Certain Officers – MSTR
-
Pomerantz Law Firm Announces the Filing of a Class Action Against Bitfarms Ltd. and Certain Officers – BITF
-
Pomerantz Law Firm Announces the Filing of a Class Action Against Civitas Resources, Inc. and Certain Officers – CIVI
-
Scatec reaches financial close for the 1.1GW solar + 100MW/200MWh BESS Obelisk project
-
Scatec signs PPA for 900MW onshore wind project in Egypt
-
Pomerantz Law Firm Announces the Filing of a Class Action Against Avis Budget Group, Inc. and Certain Officers – CAR
-
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Vestis Corporation of Class Action Lawsuit and Upcoming Deadlines - VSTS
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Petco Health and Wellness Company, Inc. - WOOF
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Take-Two Interactive Software, Inc. - TTWO
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gilead Sciences, Inc. - GILD
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ardelyx, Inc. - ARDX
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Integra LifeSciences Holdings Corporation - IART
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PTC Therapeutics, Inc. - PTCT
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Apple Inc. - AAPL
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeuroPace, Inc. - NPCE
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADTRAN Holdings, Inc. - ADTN
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Luminar Technologies, Inc. - LAZR
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Flowco Holdings Inc. - FLOC
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Globus Medical, Inc. - GMED
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Schrödinger, Inc. - SDGR
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Rocket Pharmaceuticals, Inc. - RCKT
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of 3D Systems Corporation - DDD
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Meta Platforms, Inc. - META
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Metallus Inc. - MTUS
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Travere Therapeutics, Inc. - TVTX

